HTLD Q1 2026 Earnings NarrowerThanExpected Loss Surprises Markets ARVN Q1 2026 Earnings EPS Beats Expectations as Pipeline Advances Without Revenue Pentair Q1 2026 Earnings EPS Beats Estimates by 329 Serina Therapeutics Q1 2026 Earnings EPS Misses Estimates as Stock Climbs Despite Loss RIME Q1 2026 Earnings NarrowerThanExpected Loss Drives Stock Higher STOK Q1 2026 Earnings Narrowed Loss Beats Estimates as Clinical Pipeline Advances